Skip to content

Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines

Document Type
Publications · Journal Article
Registered DB
KCISCIEScopus
Journal Ranking
JCR Q3Scopus Q2
Journal
Annals of Laboratory Medicine37(2) · pp.180 · 2017
Citation
Web of Science 15KCI 4
JCR IF
JCR 2016 2.174
ISSN
2234-3806

Authors

  1. 김솔잎First author인제대학교부속일산백병원
  2. 윤여민건국대학교
  3. 채효진가톨릭대학교
  4. 조현정건양대학교
  5. 지미숙중앙보훈병원 진단검사의학과
  6. Kim, In Suk부산대학교
  7. 이경아연세대학교
  8. 이우창울산대학교
  9. 송상훈서울대학교
  10. 우혜인성균관대학교
  11. 이수연Corresponding author성균관대학교
  12. 전사일Corresponding author울산대학교

Abstract

Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended pharmacogenetic testing guidelines for clinical application, interpretation, and result reporting through a literature review and evidence-based expert opinions for the clinical pharmacogenetic testing covered by public medical insurance in Korea. This document aims to improve the utility of pharmacogenetic testing in routine clinical settings.

Keywords

Clinical laboratoryKoreaPharmacogeneticsTestingPractice guidelineIMPLEMENTATION CONSORTIUM GUIDELINESMETASTATIC COLORECTAL-CANCERTHIOPURINE METHYLTRANSFERASE GENOTYPEWARFARIN DOSE REQUIREMENTSDRUG-METABOLIZING-ENZYMESOF-AMERICAN-PATHOLOGISTSBREAST-CANCERGENETIC POLYMORPHISMSKOREAN POPULATIONCYP2C19 GE

Identifiers

WoS UID
000391776500017
KCI
ART002204107